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line in 7 (18.4 %) patients, atrial tachycardia in 3 (7.9 %) 
patients, and additional CFAE ablation in 17 (44.7 %) pa-
tients. All 5 patients with arrhythmia recurrence had a mean 
CF < 10 g (p = 0.03).  Procedure  duration was  significantly 
shorter in the CF group (223 ± 57 vs. 256 ± 60 min, p = 0.03) 
compared with control group.
Conclusion Use of CF catheters is safe, feasible, and com-
plementary  to  a  hybrid  procedure  setup  for  atrial  fibrilla-
tion ablation. Its real-time monitoring may predict future 
arrhythmia recurrence, and decrease procedure time.
Keywords Catheter ablation · Atrial fibrillation ·  
Hybrid procedure · Contact force · Surgical ablation
Introduction
Atrial  fibrillation  (AF)  is  the  most  common  arrhythmia 
globally affecting more than 20 million people and is a lead-
ing cause of stroke among people 65 years and older [1].
During catheter ablation for a cardiac arrhythmia, energy 
is delivered to areas of interest of the heart muscle that are 
causing the abnormal heart rhythm. Reconduction across an 
ablation line is one of the most frequent reasons for arrhyth-
mia recurrence over time, e.g. pulmonary vein (PV), and 
linear lesions [2]. The hybrid procedure combines the epi-
cardial ablation of PVs and creation of the box lesion by the 
cardiac surgeon and endocardial touch-ups (only if needed) 
to ensure ablation of any missed electrical gaps, by the elec-
trophysiologist [3–5]. To create a transmural lesion, contact 
force (CF) between the ablation tip and cardiac tissue is a 
major determining parameter for radiofrequency catheters, 
thus its monitoring assumes significance [6]. Low CF may 
lead to an inadequate lesion. However, if it is very high, it 
may increase  the  risk of significant complications such as 
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thrombus formation, catheter tip charring, steam pop for-
mation and also cardiac perforation. To date CF catheters 
have never been used in a hybrid procedure setting for AF 
ablation.
To the best of our knowledge,  this  is  the first article  to 
study the safety and feasibility of using a CF catheter during 
the hybrid ablation of AF.
Methods
Study population
Thirty-eight patients with symptomatic AF underwent the 
hybrid procedure using the epicardial bipolar RF devices 
and an endocardial CF catheter. The definitions of paroxys-
mal, persistent, long-standing persistent, and permanent AF, 
success and failure of ablation, and follow-up monitoring 
were based on the consensus statement of the Heart Rhythm 
Society, the European Heart Rhythm Association, and Euro-
pean Cardiac Arrhythmia Society.
Selection criteria of AF patients for this procedure were 
previously failed catheter ablation, failure of at least one anti-
arrhythmic drug (AAD), left atrial volume ≥ 55 ml, or patient 
preference for a hybrid procedure instead of a percutaneous 
approach. Prior catheter ablation was noted in the history 
for 18/38 AF patients (47.4 %) and 11/38 patients (29 %) 
had prior catheter ablation for cavo-tricuspid isthmus (CTI) 
dependent atrial flutter. The preoperative work-up consisted 
of transthoracic echocardiography, cardiac computed tomog-
raphy (for assessing PV anatomy and integration to electro-
anatomical mapping), and pulmonary function testing.
Control group
A random, retrospective and randomised control group of 
30 patients with similar patient characteristics (Table 1) was 
selected, to compare the endocardial ablation parameters, 
e.g. fluoroscopy time, procedure time and ablation time with 
a similar ablation setting of the radiofrequency generator. A 
standard non-force sensing irrigated tip catheter (Thermo-
Cool, Biosense Webster) was used during a hybrid proce-
dure for the patients in the control group.
Hybrid procedure
The hybrid procedure was performed as described elsewhere 
[3, 4, 7]. Briefly, all AADs were stopped before the proce-
dure (considering their half-life) except amiodarone. Under 
general anaesthesia, after introducing two 5 mm working 
ports and a 5 mm video port in the intercostal spaces of the 
left and right hemithorax, patients underwent PV isolation 
using epicardial bipolar radiofrequency clamps (Atricure, 
West Chester, OH, USA). An epicardial box lesion was 
made using a bipolar radiofrequency pen or a linear pen 
device (Coolrail, Atricure) consisting of a roof line (con-
necting both superior PVs) and an inferior line (connecting 
both inferior PVs). Using left femoral vein access, catheters 
were placed in the His bundle and coronary sinus. Using 
a single transseptal puncture a circular mapping catheter, 
according to the size of the PV (Lasso, Biosense Webster 
Inc., Diamond Bar, USA), was placed ostially to assess the 
PV potentials. The electrophysiologist checked for electrical 
isolation of ablation lines by pacing manoeuvres, electro-
anatomical mapping and/or adenosine bolus administration. 
A CARTO platform (CARTO-3; Biosense Webster, Dia-
mond Bar, CA) was used for electroanatomical mapping. A 
left atrium shell was created using point-by-point acquisi-
tion with the aid of the CF catheter (SmartTouchTM, Bio-
sense Webster Inc.). Criteria for an adequate left atrial shell 




Age (years) 61.8 ± 7.2
BMI (kg/m2) 28.2 ± 3.4
Tested pulmonary veins (n, %) 150(100)
Touch up needed in pulmonary veins (n, %) 2 (1.3)
Tested box lesions (n, %) 37 (97.4)
Touch up needed in box (n, %) 10 (27 )
Additional CTI ablation (n, %) 7 (18.4)
Additional atrial tachycardia ablation (n, %) 3 (7.9)
Additional mitral line ablation (n, %) 0 (0)
Additional CFAE ablation (n, %) 17 (44.7)
Average procedure time (minutes) 223 ± 57
Medical history
Hypertension (n, %) 16 (42.1)
Diabetes (n, %) 5 (13.2)
CAD (n, %) 15 (39.5)
COPD (n, %) 2 (5.3)
Medication use
Amiodarone (n, %) 5 (13.2)
Flecainide (n, %) 19 (50)
Sotalol (n, %) 8 (21.0 )
Disease characteristics
Paroxysmal/persistent/permanent AF (n/n/n, 
%/%/%)
14,19,5 (37,50,13)
AF duration (years, mean ± SD) 6.8 ± 4.352 ± 14
LVEF (%, mean ± SD) 93 ± 25
Volume (ml, mean ± SD)
of prior catheter ablations (n, %)
18 (47.4)
Number of prior electrical/pharmacological 
cardioversions (n, %)
26 (68.4 )
AF  atrial  fibrillation,  AFl  atrial  flutter,  BMI body mass index, n 
numbers, CTI cavo tricuspid isthmus, CAD coronary artery disease, 
CFAE complex fractionated atrial electrograms, CHF congestive 
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tion and box lesion. The spatial distribution of CFAE in 
the left atria of AF patients was evaluated using software 
designed to automatically identify CFAE in the framework 
of the CARTO platform. In detail, the minimal amplitude 
threshold and maximal amplitude threshold were set to 
± 0.05 millivolt (mV) and ± 0.15 mV, and the minimal and 
maximal intervals between two consecutive peaks were set 
to 60 msec and 120 msec [8].
After  finishing  the  endocardial  ablation,  and  retesting 
for arrhythmia, the induction was performed. The left atrial 
appendage (LAA) was removed using a stapling device in 
11 patients. Finally, bilateral chest drains were inserted in 
were: ≥ 100 points, which were homogenously distributed 
to create the entire chamber.
The CF catheter was further used for endocardial abla-
tion (if needed) to complete the PV isolation and box lesion, 
while maintaining the CF values between 10–40 G with the 
aid of a Stockert 70 radiofrequency generator (Biosense 
Webster) with a maximal temperature of 43 °C and limited 
to 25 W at the posterior wall (Fig. 1). Endocardial ablation 
was also used for CTI ablation in patients with a prior his-
tory  of  atrial  flutter,  any  inducible  atrial  tachycardia,  and 
complex fractionated atrial electrogram (CFAE) ablation 
is used in case of persistent AF after epicardial PV isola-
Fig. 1 Endocardial radiofre-
quency ablation (red dots) using 
CF catheter for completion of the 
inferior line of box lesion. a At 
start of ablation. b After finishing 
ablation. We can further notice 
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17.6 ± 7.8 g for the right PVs and 15.7 ± 7.2 g for the left 
PVs. Further details on the lesion sets and patient character-
istics are shown in Table 1.
The control group consisted of 30 patients (paroxysmal: 
11 (37 %), persistent: 16 (53 %), permanent = 3 (10 %)). 
The mean left atrial volume was 91 ± 23 ml. The statisti-
cal analysis (using the Mann–Whitney test) for procedure 
duration was significantly shorter in the CF group (223 ± 57 
vs. 256 ± 60 min, p = 0.03) compared with the control group. 
There were no statistically significant differences observed 
in ablation time (11.2 ± 5.9 vs 14.1 ± 6.2 min) or fluoroscopy 
time (18.5 ± 8.6 vs 23.4 ± 6.4 min) although all were reduced 
in the CF group. No difference in complications was seen 
between the groups. After a mean follow-up of 357 ± 43 
days (395–334 days) for control group patients, 75 % of 
patients were AF free without AADs.
Follow-up
During  the first 3 months after  the procedure,  the patients 
were blanked for the analysis of recurrence of AF. After 
follow-up of 335 ± 66.5 days (410–320 days), 33/38 patients 
(86.8 %) of the study population were in sinus rhythm 
without AADs, 2 patients needed AADs to maintain sinus 
rhythm. Catheter ablation was needed for 3 patients i.e. 
1  typical  CTI  dependent  atrial  flutter,  1  mitral  isthmus 
dependent flutter, and an atrial  tachycardia. Non-inducible 
patients, who were tested immediately after ablations, 
had less arrhythmia during follow-up than inducible ones 
(p = 0.04). Among all patients with recurring arrhythmia, we 
retrospectively observed that they had received endocardial 
touch-up; the mean CF was < 10 g (p = 0.03), in spite of con-
tinuous attempts to improve the contact. Figure 3 shows a 
Kaplan-Meier graph of AF-free survival.
Adverse events
No thromboembolic complications or conversion to cardio-
pulmonary bypass were encountered. No signs of infection 
and phrenic nerve paralysis were seen among any of the 
patients. One patient had recurrent pain in the left thorax 
region a few weeks after the procedure. Diagnosis of atrau-
matic  lung  hernia  was  confirmed  by  high-resolution  com-
puterised tomographic (HRCT) [9, 10]. Retrospectively, the 
aetiology was attributed to widening of the mini invasions of 
12 mms (initially) to 3 cm to accommodate an epicardial left 
atrial appendage (LAA) clip. To the best of our knowledge, 
this is the only case of atraumatic lung hernia secondary to 
usage of an LAA clip in the literature. No other complications 
were associated with such clip usage. No signs of PV stenosis 
were seen in any patient during follow-up HRCT [11].
the pleural cavities. Patients were extubated in the operating 
room before being transferred to the ICU. Within 6 h, low-
molecular-weight heparin was started and acenocoumarol 
was restarted after 2 days. AADs were restarted as soon as 
possible. After confirming absence of atrial arrhythmias after 
6 months, AADs and anticoagulation were discontinued.
Follow-up
Follow-up was conducted at our hospital’s outpatient clinic 
in the 3rd, 6th, 9th, 12th month after the procedure. A 7-day 
Holter monitoring was used for all patients; if not available 
patients underwent at least 48-hour Holter monitoring (3 
patients). Arrhythmia recurrence was considered to be any 
episode of AF, flutter or tachycardia lasting more than 30 s 
detected after the 3-month blanking period.
Statistical analysis
Continuous variables are expressed as mean ± standard 
deviation. Data were retrospectively entered into a database. 
Statistical analysis was performed using SPSS 16.0 (SPSS 
Inc, Chicago, IL). Event-free survival was estimated using 
Kaplan-Meier and compared by the log-rank test. Possible 
predictors of arrhythmia recurrence were performed using 
the Cox proportional hazards regression models. A p value 
of < 0.05 was considered significant.
Results
The study group consisted of 38 patients (61.8 ± 7.2 years; 
34 male) with AF duration of 6.8 ± 4.3 years. A left-sided 
common ostium was observed in 2 patients. The body mass 
index was 28.2 ± 3.4 kg/m2. Eighteen patients had under-
gone catheter PV isolation. Electrical/pharmacological 
cardioversions were attempted previously for 26 patients 
(68.4 %). The mean procedure time (from initial skin inci-
sion to skin closure) was 223 ± 57 min. The mean left atrium 
size was 93 ± 25 ml, with a mean left ventricular ejection 
fraction of 52 ± 14 %. Epicardial bipolar radiofrequency 
devices were used for 150 PVs (100 %) and 37 box lesions 
(100 %) for 38 patients. Endocardial touch-up using a CF 
catheter was needed for 2 PVs (1.3 %) of different patients, 
i.e. left superior PV and right inferior PV, and for 10 box 
lesions (26.3 %). A total of 4 touch-up lesions with a mean 
duration of 39 s were applied to the PVs. It was also used for 
creation of a CTI line in 7 (18.4 %) patients and additional 
CFAE ablation in 17 (44.7 %) patients. Further, during burst 
pacing to test for inducible AF, 3 (7.9 %) patients developed 
5 different morphologies of inducible atrial tachycardia and 
henceforth CF was also used for endocardial ablation for all 
of them. The mean grams of force per ablation lesion were 
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radiofrequency delivery  in areas with  insufficient  tissue 
electrode contact substantially reduced energy delivery. 
These  catheters  also  significantly  reduced  ablation  and 
procedural times in PV isolation [6]. Continuous moni-
toring of CF values may help to provide extra helpful 
information to the operating physician for safer catheter 
manipulation. It helps to make an AF ablation procedure 
safer as high CF values may occur, not only during cath-
eter manipulation but also during ablation (Fig. 2 and 
video 1, [27]).
Discussion
This  manuscript  describes,  for  the  first  time,  combined 
simultaneous thoracoscopic epicardial ablation using bipo-
lar devices and endocardial ablation using CF catheters 
for paroxysmal and persistent AF. Further, the use of a CF 
catheter results in superior transmurality of linear ablation 
lesions.
The pharmacological approach with AADs has not 
achieved optimal results in the long-term maintenance of 
sinus rhythm in patients with AF [12−14]. Considering the 
limitations of medical therapy, there has been an upsurge 
in catheter and surgical ablation techniques for AF ablation 
[15−17]. The recently proposed hybrid approach combines 
the advantages of individual approaches while simultane-
ously doing away with their disadvantages, complications, 
and ultimately ensuring the transmurality of lesions [3, 5, 
18]. AF recurrence is often associated with PV reconnec-
tion after initial PV ablation [19−23]. It is attributed to the 
inability of endocardial catheter based ablation techniques 
to guarantee long-lasting transmurality of the lesions [2].
Both ablation technologies used in this setup share 
common principles. An epicardial bipolar radiofrequency 
device (Atricure Inc.) works on the principle of imped-
ance change and endocardial ablation using a CF catheter 
works on CF measurement. Interestingly, several studies 
have correlated impedance drop with CF with due credit 
to the more detailed quantitative analysis and use of non-
parametric statistics [24−26]. Martinek et al. found that 
the use of CF sensing technology catheters significantly 
reduces ablation time, translating to an overall reduc-
tion in procedural times in PV isolation. This reasoning 
is well suited to the hybrid procedure as well. Avoiding 
Fig. 2 Temporal display of 
change of contact force (grey 
colored) with time during endo-
cardial radiofrequency ablation 
(red dots)
 
Fig. 3 Kaplan–Meier survival curve of atrial arrythmia free survival 
after a single hybrid procedure after a blanking period of 90 days for 
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is less invasive with minimum complications, unlike the 
pure surgical approach. The wastage of unnecessary energy 
delivery with CF catheters was avoided in three way: firstly 
by simultaneous epicardial ablation, secondly by visualis-
ing the electrical gaps by pacing manoeuvres and electro-
anatomical mapping  and,  finally  by  avoiding  ablations  in 
locations  with  insufficient  surface  contact. Moreover,  the 
success rate of this procedure is comparable with either 
approach individually, especially considering the dilated 
left atrium and long years of AF duration. Monitoring of 
CF values during ablation can control the success rate of 
the procedure.
Study limitations
The small number of patients and a control group in this 
single-centre retrospective study prevents definitive conclu-
sions. However, future larger, long-term and multicentre 
studies may corroborate our results.
Conclusion
Use of CF catheters is safe, feasible, and complementary to 
a hybrid procedure setup for AF ablation. The monitoring of 
real-time CF values predicts future arrhythmia recurrence 
and decreases procedure time.
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